ed from page 399 of the application) Fellowship training in medical oncology and gynecologic oncology usually emphasizes clinical care and clinical trials. Few graduates of such programs receive training that allows them to develop independent laboratory or translational research programs. Likewise, research specifically related to ovarian cancer is not well represented in the basic sciences. Thus, there is a shortage of physician- scientists and scientists working in ovarian cancer research. This program is designed to develop academic physician-scientists and scientists with research interests in ovarian cancer. To this end, we are budgeting for support of three career development trainees annually. The program has the following objectives: (1) to recruit and train physicians and post-doctoral fellows in research methodologies that will enable them to become competent translational investigators in the field of ovarian cancer; (2) to teach those basic principles of cancer biology that are not commonly included in clinical fellowship training programs or Ph.D. degree programs. It is proposed that these objectives will be accomplished through a strong mentorship program in which trainees are instructed in scientific methods, statistical analysis, biomedical communications, the principles of cancer biology, and strategies to become successful in the translational research of ovarian cancer. Thus, the program will develop trainees who can readily identify basic science findings with translational potential and design protocols for clinical trials based on that translation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA083639-01
Application #
6228666
Study Section
Special Emphasis Panel (ZCA1-GRB-4 (O1))
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Seo, Hyeonglim; Choi, Ikjang; Whiting, Nicholas et al. (2018) Hyperpolarized Porous Silicon Nanoparticles: Potential Theragnostic Material for 29 Si Magnetic Resonance Imaging. Chemphyschem 19:2143-2147
Mitamura, T; Pradeep, S; McGuire, M et al. (2018) Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene 37:722-731
Yuan, Jiao; Hu, Zhongyi; Mahal, Brandon A et al. (2018) Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell 34:549-560.e9
Liu, Xiaojun; Jiang, Yingjun; Nowak, Billie et al. (2018) Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations. Cancer Chemother Pharmacol 81:255-267
Haemmerle, Monika; Stone, Rebecca L; Menter, David G et al. (2018) The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell 33:965-983
Allen, Julie K; Armaiz-Pena, Guillermo N; Nagaraja, Archana S et al. (2018) Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. Cancer Res 78:3233-3242
Umamaheswaran, Sujanitha; Dasari, Santosh K; Yang, Peiying et al. (2018) Stress, inflammation, and eicosanoids: an emerging perspective. Cancer Metastasis Rev 37:203-211
Wang, Jue; Zhao, Wei; Guo, Huifang et al. (2018) AKT isoform-specific expression and activation across cancer lineages. BMC Cancer 18:742
Huang, Yan; Hu, Wei; Huang, Jie et al. (2018) Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer. Mol Cancer Ther 17:464-473
Yang, Hailing; Mao, Weiqun; Rodriguez-Aguayo, Cristian et al. (2018) Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Clin Cancer Res 24:5072-5084

Showing the most recent 10 out of 648 publications